P PRIMESTOCKFINDER.COM

FPH Shares Fisher & Paykel Healthcare Corporation Limited

BUY ASX · ASX
$39.03 -1.44% Prices as of close 2026-10-26

RBC overweight stance, recurring respiratory demand, and premium international franchise support sustained growth.

Future value: $37.32 (-4.38%) · 6-12 months · analyst consensus

Signal breakdown

  • ▸RBC overweight call and positive sector earnings outlook
  • ▸Above 50-day MA (+5.4%)
  • ▸Above 200-day MA — long-term uptrend
  • ▸Volume 1.56× average — accumulation
  • ▸Near 52-week high (91.8% of range) — strength
  • ▾Trading above its price target — limited upside

Is FPH a buy right now?

Trend: FPH is trading above the 50-day average (+6.68%), RSI 42 — neutral momentum, with a 3-month return of +15.65%.

Valuation & quality: Fisher & Paykel Healthcare Corporation Limited trades on a trailing P/E of 56.6, forward P/E 44.7, PEG 43.63, price-to-book 13.54; fundamentals show net margin 20.3%, return on equity 23.4%, revenue growth 14.0% year on year.

Analyst consensus: 8 analysts have a mean 12-month price target of A$37.27 (-4.5% vs the last close; range A$25.66 – A$43.87), consensus rating “buy”.

Income: trailing dividend yield 1.10%.

Our screen: BUY (score 3) — RBC overweight stance, recurring respiratory demand, and premium international franchise support sustained growth.

Computed from end-of-day data; not personal advice.

12-month price chart

39.9 26.7 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-26 (AUD). Range 26.7 – 39.9.

Monthly returns

Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-10.00%-3.80%+4.50%+2.80%+6.10%+6.80%+3.00%+5.80%

Fundamentals

Market cap
$23.30B
P/E (ttm)
56.6
Forward P/E
44.7
EPS (ttm)
$0.70
Price / book
13.54
PEG
43.63
Beta
0.88
Net margin
20.3%
ROE
23.4%
Revenue growth
14.0%
Earnings growth
14.3%
Revenue (ttm)
$2.31B
Free cash flow
$399.4M
Debt / equity
7%
Dividend yield
1.10%
52-wk range
$26.51 – $40.15
Volume
540,304
Avg volume (3m)
407,718

Analyst price target

Mean target
$37.27
Low
$25.66
High
$43.87
Analysts
8
Consensus
BUY

Technical signals

RSI (14)
41.6
vs 50-day MA
+6.68%
1-mo return
+8.61%
3-mo return
+15.65%
Volume z-score
-0.16

About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally.

Sector: Healthcare · Industry: Medical Instruments & Supplies · New Zealand · 7,357 employees · Website

Related Health Care picks

CSL.AXCSL LimitedPME.AXPro Medicus LimitedCOH.AXCochlear LimitedRMD.AXResMed Inc.RHC.AXRamsay Health Care LimNAN.AXNanosonics LimitedSIG.AXSigma Healthcare LimitEBO.AXEBOS Group Limited

Browse: all ASX stocks · Health Care picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.